EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Special Issue “Hybrid Drugs: Design and Applications”

Parvesh Singh, Vipan Kumar iD

Pharmaceuticals · 26.09.2023 · 16 (10) · 1358

DOI: 10.3390/ph16101358 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 26.09.2023. Verfasst von Parvesh Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban 4000, South Africa. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The widely held belief in the potential superiority of agents capable of modulating multiple biological targets has led to the adoption of molecular hybridization as an effective technique in the realm of drug discovery and development [...]

Autor:innen und Institutionen

  • School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban 4000, South Africa.
  • Department of Chemistry, Guru Nanak Dev University, Amritsar 143005, India.

ORCID-Profile: Vipan Kumar

Zitieren

APA

Singh, P., & Kumar, V. (2023). Special Issue “Hybrid Drugs: Design and Applications”. Pharmaceuticals, 16(10), 1358. https://doi.org/10.3390/ph16101358

Vancouver

Singh P, Kumar V. Special Issue “Hybrid Drugs: Design and Applications”. Pharmaceuticals. 2023;16(10):1358. doi:10.3390/ph16101358

BibTeX
@article{Singh2023,
  author = {Singh, Parvesh and Kumar, Vipan},
  title = {Special Issue “Hybrid Drugs: Design and Applications”},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {10},
  pages = {1358},
  doi = {10.3390/ph16101358}
}
Kostenlos starten →